BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 31404023)

  • 21. Cyst Fluid Analysis in Pancreatic Intraductal Papillary Mucinous Neoplasms.
    Allen PJ; Iacobuzio-Donahue CA; Klimstra DS
    Clin Cancer Res; 2016 Oct; 22(20):4966-4967. PubMed ID: 27573170
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cyst fluid amylase and CEA levels in the differential diagnosis of pancreatic cysts: a single-center experience with histologically proven cysts.
    Oh HC; Kang H; Brugge WR
    Dig Dis Sci; 2014 Dec; 59(12):3111-6. PubMed ID: 24965184
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intraductal papillary mucinous neoplasms of the pancreas: performance of pancreatic fluid analysis for positive diagnosis and the prediction of malignancy.
    Maire F; Voitot H; Aubert A; Palazzo L; O'Toole D; Couvelard A; Levy P; Vidaud M; Sauvanet A; Ruszniewski P; Hammel P
    Am J Gastroenterol; 2008 Nov; 103(11):2871-7. PubMed ID: 18775021
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vascular endothelial growth factor, a novel and highly accurate pancreatic fluid biomarker for serous pancreatic cysts.
    Yip-Schneider MT; Wu H; Dumas RP; Hancock BA; Agaram N; Radovich M; Schmidt CM
    J Am Coll Surg; 2014 Apr; 218(4):608-17. PubMed ID: 24491241
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Gastric Glycoform of MUC5AC Is a Biomarker of Mucinous Cysts of the Pancreas.
    Sinha J; Cao Z; Dai J; Tang H; Partyka K; Hostetter G; Simeone DM; Feng Z; Allen PJ; Brand RE; Haab BB
    PLoS One; 2016; 11(12):e0167070. PubMed ID: 27992432
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Humoral Predictors of Malignancy in IPMN: A Review of the Literature.
    Nista EC; Schepis T; Candelli M; Giuli L; Pignataro G; Franceschi F; Gasbarrini A; Ojetti V
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884643
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The association between serum ferritin levels and malignant intraductal papillary mucinous neoplasms.
    Zhuge X; Zhou H; Chen L; Chen H; Chen X; Guo C
    BMC Cancer; 2021 Nov; 21(1):1253. PubMed ID: 34800987
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolomic-derived novel cyst fluid biomarkers for pancreatic cysts: glucose and kynurenine.
    Park WG; Wu M; Bowen R; Zheng M; Fitch WL; Pai RK; Wodziak D; Visser BC; Poultsides GA; Norton JA; Banerjee S; Chen AM; Friedland S; Scott BA; Pasricha PJ; Lowe AW; Peltz G
    Gastrointest Endosc; 2013 Aug; 78(2):295-302.e2. PubMed ID: 23566642
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Implications of imaging criteria for the management and treatment of intraductal papillary mucinous neoplasms - benign versus malignant findings.
    Walter TC; Steffen IG; Stelter LH; Maurer MH; Bahra M; Faber W; Klein F; Bläker H; Hamm B; Denecke T; Grieser C
    Eur Radiol; 2015 May; 25(5):1329-38. PubMed ID: 25433414
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinicopathological Meaning of Size of Main-Duct Dilatation in Intraductal Papillary Mucinous Neoplasm of Pancreas: Proposal of a Simplified Morphological Classification Based on the Investigation on the Size of Main Pancreatic Duct.
    Kang MJ; Jang JY; Lee S; Park T; Lee SY; Kim SW
    World J Surg; 2015 Aug; 39(8):2006-13. PubMed ID: 25894399
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The discrete nature and distinguishing molecular features of pancreatic intraductal tubulopapillary neoplasms and intraductal papillary mucinous neoplasms of the gastric type, pyloric gland variant.
    Yamaguchi H; Kuboki Y; Hatori T; Yamamoto M; Shimizu K; Shiratori K; Shibata N; Shimizu M; Furukawa T
    J Pathol; 2013 Nov; 231(3):335-41. PubMed ID: 23893889
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distinction of Invasive Carcinoma Derived From Intraductal Papillary Mucinous Neoplasms From Concomitant Ductal Adenocarcinoma of the Pancreas Using Molecular Biomarkers.
    Tamura K; Ohtsuka T; Date K; Fujimoto T; Matsunaga T; Kimura H; Watanabe Y; Miyazaki T; Ohuchida K; Takahata S; Ishigami K; Oda Y; Mizumoto K; Nakamura M; Tanaka M
    Pancreas; 2016 Jul; 45(6):826-35. PubMed ID: 26646266
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Emerging role of tumor markers and biochemistry in the preoperative invasive assessment of intraductal papillary mucinous neoplasm of the pancreas.
    You L; Ma L; Zhao WJ; Zhao YP; Dai MH
    Clin Chim Acta; 2016 Feb; 454():89-93. PubMed ID: 26746574
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Simple Detection of Telomere Fusions in Pancreatic Cancer, Intraductal Papillary Mucinous Neoplasm, and Pancreatic Cyst Fluid.
    Hata T; Dal Molin M; McGregor-Das A; Song TJ; Wolfgang C; Eshleman JR; Hruban RH; Goggins M
    J Mol Diagn; 2018 Jan; 20(1):46-55. PubMed ID: 29229290
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preoperative GNAS and KRAS testing in the diagnosis of pancreatic mucinous cysts.
    Singhi AD; Nikiforova MN; Fasanella KE; McGrath KM; Pai RK; Ohori NP; Bartholow TL; Brand RE; Chennat JS; Lu X; Papachristou GI; Slivka A; Zeh HJ; Zureikat AH; Lee KK; Tsung A; Mantha GS; Khalid A
    Clin Cancer Res; 2014 Aug; 20(16):4381-9. PubMed ID: 24938521
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The natural history of main duct-involved, mixed-type intraductal papillary mucinous neoplasm: parameters predictive of progression.
    Roch AM; Ceppa EP; Al-Haddad MA; DeWitt JM; House MG; Zyromski NJ; Nakeeb A; Schmidt CM
    Ann Surg; 2014 Oct; 260(4):680-8; discussion 688-90. PubMed ID: 25203885
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyst fluid SPINK1 may help to differentiate benign and potentially malignant cystic pancreatic lesions.
    Räty S; Sand J; Laukkarinen J; Vasama K; Bassi C; Salvia R; Nordback I
    Pancreatology; 2013; 13(5):530-3. PubMed ID: 24075519
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pancreatic resection for intraductal papillary mucinous neoplasm- a thirteen-year single center experience.
    Marsoner K; Haybaeck J; Csengeri D; Waha JE; Schagerl J; Langeder R; Mischinger HJ; Kornprat P
    BMC Cancer; 2016 Nov; 16(1):844. PubMed ID: 27809876
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Simultaneous and sequential combination of genetic and epigenetic biomarkers for the presence of high-grade dysplasia in patients with pancreatic cyst: Discovery in cyst fluid and test in pancreatic juice.
    Hata T; Mizuma M; Kusakabe T; Amano H; Furukawa T; Iwao T; Unno M
    Pancreatology; 2023 Mar; 23(2):218-226. PubMed ID: 36707261
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An integrated analysis of host- and tumor-derived markers for predicting high-grade dysplasia and associated invasive carcinoma of intraductal papillary mucinous neoplasms of the pancreas.
    Hata T; Mizuma M; Motoi F; Ishida M; Morikawa T; Nakagawa K; Hayashi H; Kanno A; Masamune A; Kamei T; Naitoh T; Furukawa T; Unno M
    Surg Today; 2020 Sep; 50(9):1039-1048. PubMed ID: 32124086
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.